Colorectal Cancer, Gastric Cancer, Gastrointestinal Disease
Conditions
Brief summary
This is a multi-centered, retrospective, observational study aimed at observing the current status of the management of gastrointestinal surgery during the COVID-19 pandemic, particularly the changes on surgery protocols and other key aspects of surgical workflow, so as to share experience with colleagues both domestic and abroad.
Interventions
OTHERno intervention
no intervention
Sponsors
Peking University First Hospital
Peking University People's Hospital
Peking University Third Hospital
Chinese PLA General Hospital
Beijing Hospital
Xuanwu Hospital, Beijing
Peking Union Medical College Hospital
Beijing Chao Yang Hospital
Peking University Cancer Hospital & Institute
China-Japan Friendship Hospital
Peking University Shougang Hospital
Beijing Friendship Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* All patients arriving at surgical emergency and all patients receiving gastrointestinal surgeries in participating centers from 2020.1.1\ 2020.3.31.
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| treatment of fevers at arrival | 1 day | proportion of patients presented with fever, proportion of patients refered to fever clinics, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?) |
| treatment of post-operative fevers | 1 day | proportion of patients on whom fever occured, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?) |
| assorted surgical parameters | 1 day | Duration of operation (≥180min/\<180min); Intra-operative transfusion (Y/N); Surgical approach (Laparoscopy-involved/Open); Resection range (Non-radical/Radical); Lymph node dissection (Unknown/Not dissected/D1/D2 or above); Combined organ resection (Y/N); Post-operative complications (Y/N); Post-operative transfusion (Y/N); Post-operative hospital stay (≥7d/\<7d) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| hospitals' protection measures and extent of implementation | 1 month | Out-patient of surgery (Open/Closed); Emergency of surgery (Open/Closed); Fever clinic (Open/Closed); Surgical ward (Open/Closed); Functional level of surgical ward (Receive emergency surgery patients only/Receive surgery patients only/Receive all kinds of patients); Isolation ward for suspected COVID-19 patients (With/Without); Bed number in each surgical ward room (1/2/≥3); Isolation area within surgical ward (With/Without); Usage of sub-pressure operation theaters (Routinely applied/Applied for suspected patients/Never applied); Protection level of surgeons in surgical ward (No specific protection/Regular medical masks/Any of N95 mask, eye/face shields, gowns); Protection level of surgeons in ER room (No specific protection/Regular medical masks/Any of N95 mask, eye shields, face shields, gowns) |
Contacts
Primary ContactKai Pang, M.D.
Outcome results
None listed